CD8A and melanoma: Furthermore, we observed a negative correlation of DUSP6 and SPRY4, two negative feedback regulators of MAPK signaling43,44 with the presence of CD8+ T-cells in pre-, but not in on-treatment BRAF-mutant melanoma patients (Fig. 2h, left, Supplementary Fig. 4q–s).